Lovell, Daniel J <br/><br/>
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  Oct 2015 
 - 2759-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.39234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept--adverse effects<br/>Activities of Daily Living--psychology<br/>Adolescent<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Juvenile--drug therapy<br/>Child<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Psychology<br/>Quality of Life--psychology<br/>Self Report<br/>Surveys and Questionnaires<br/>Time Factors<br/>Treatment Outcome